🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-10-02
Trial ID
NCT01896271
Treatments Being Tested
Stereotactic ablative body radiotherapy (SABR), or stereotactic body radiot...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-05-12
Trial ID
NCT03159676
Treatments Being Tested
Aims: To increase the number of patients that benefit from Stereotactic Abl...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07
Trial ID
NCT04928755
Men with oligometastatic prostate cancer lesions will be randomized (1:2) t...
Status
Completed
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2016-04-28
Trial ID
NCT02680587
Treatments Being Tested
A one-arm, single center phase 2 trial of SAbR plus ipilimumab plus nivolum...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center - Dallas
Start Date
2018-03-01
Trial ID
NCT03126461
Treatments Being Tested
Prostate Stereotactic ablative body radiotherapy (SABR) is an established t...
Status
Recruiting
Location
Sunnybrook Health Sciences Centre
Start Date
2024-03-01
Trial ID
NCT05600400
Treatments Being Tested
In order to better understand radiation-induced lung toxicity, the investig...
Status
Terminated
Location
Ummc Msgcc
Start Date
2017-06-01
Trial ID
NCT02745548
This is a prospective, single-arm, single-center Phase II clinical study. I...
Status
Not Yet Recruiting
Location
Xinxiang Li
Start Date
2024-11-01
Trial ID
NCT06593548
Treatments Being Tested
The purpose of this clinical trial is to determine whether using chemothera...
Status
Recruiting
Location
Miami Cancer Institute at Baptist Health, Inc.
Start Date
2023-09-21
Trial ID
NCT05679674
Treatments Being Tested
This phase I trial studies the side effects of atezolizumab, varlilumab, an...
Status
Terminated
Location
Rutgers Cancer Institute of New Jersey
Start Date
2019-09-11
Trial ID
NCT04081688
Treatments Being Tested